This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Ensign Group Surges 51.8% in a Year: More Room for Upside?
by Zacks Equity Research
Ensign Group's (ENSG) inorganic growth strategies should lead to healthy revenues. This will likely bump up its share price further.
Molina (MOH) Stock Surges 34% in a Year: More Room to Run
by Zacks Equity Research
Molina's (MOH) restructuring plan should aid revenue growth. This will likely drive its share price further.
Top Ranked Growth Stocks to Buy for July 9th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 9th
UnitedHealth's Stock Down in 1H19: What Lies Ahead in 2H?
by Zacks Equity Research
Regulatory disturbances weigh on UnitedHealth's (UNH) stock in the first half of 2019. However, the company is likely to get support from its strong business model.
3 Healthcare Stocks to Stay on Your Watch List for 2H19
by Zacks Equity Research
Banking on Medicaid and Medicare business, these three stocks should remain in your focus for the second half of 2019.
HCA Healthcare Buys Urgent Care Centers to Boost Portfolio
by Zacks Equity Research
HCA Healthcare (HCA) acquires urgent care centers in Austin, Dallas and Houston to enhance its portfolio.
Ensign Group (ENSG) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Ensign Group (ENSG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
MOH vs. JYNT: Which Stock Is the Better Value Option?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
Molina (MOH) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Molina (MOH) closed at $142.87, marking a +1.08% move from the previous day.
Zacks.com featured highlights include: BioDelivery, Ciena, United States and Molina
by Zacks Equity Research
Zacks.com featured highlights include: BioDelivery, Ciena, United States and Molina
Should Value Investors Buy Molina (MOH) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
UnitedHealth to Buy Equian & Foray into Healthcare Payments
by Zacks Equity Research
UnitedHealth (UNH) is mulling to buy Equian and enter into the expanding healthcare payments space, as per sources.
Moving Average Crossover Alert: Molina Healthcare
by Zacks Equity Research
Molina Healthcare, Inc. (MOH) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Focus on 4 Liquid Picks on the Top Rung for Robust Returns
by Zacks Equity Research
Here are four top-ranked liquid stocks that investors can cling on to for significant returns.
Zacks.com featured highlights include: Brinker, Sonic Automotive, Molina, American Financial and Invitation Homes
by Zacks Equity Research
Zacks.com featured highlights include: Brinker, Sonic Automotive, Molina, American Financial and Invitation Homes
5 Best GARP Stocks With Discounted PEG
by Urmimala Biswas
A lower PEG ratio, preferably less than 1, is always better for GARP investors.
Tenet Healthcare Strikes Deal for Revenue Cycle Management
by Zacks Equity Research
Tenet Healthcare's (THC) subsidiary Conifer forms a new revenue cycle management alliance with a member of D-HH.
Upgraded Broker Ratings Make These 5 Stocks Worth Betting on
by Swayta Shah
After thorough research, brokers decide to rate a particular company's stock. So, when a broker upgrades a stock, one can rely on it.
Why Should You Add Magellan Health to Your Portfolio?
by Zacks Equity Research
Banking high on wise strategic measures and a favorable operating performance, Magellan Health (MGLN) can be added to your portfolio.
Trade Negotiations Can Work or Fail
by John Blank
Two clean tracks set the event risk.
Molina (MOH) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Molina (MOH) closed the most recent trading day at $146.37, moving +0.36% from the previous trading session.
Why it is Worth Betting on Cigna Stock for Your Portfolio
by Zacks Equity Research
Banking on prudent buyouts and solid overseas business, Cigna (CI) holds immense potential to reap benefits for investors.
Wall Street Foresees a Fed Rate Cut: Winners & Losers
by Tirthankar Chakraborty
Some analysts have started to price in "insurance cuts," which means they are expecting the Fed to cut rates right before a downturn in order to save the economy.
The Zacks Analyst Blog Highlights: Air China, Molina and AngloGold
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Air China, Molina and AngloGold
MEDNAX Forges Alliance for Better Health Services in Texas
by Zacks Equity Research
MEDNAX (MD) collaborates with Alfredo Gei MD, P.A. to provide patients with better healthcare services in Houston.